Research Interests
Bivalent CD47 immunotoxin for targeted therapy of T-cell acute lymphoblastic leukemia.
CCR4-IL2 bispecific immunotoxin for targeted therapy for cutaneous T-cell lymphoma.
Anti-porcine CD3 immunotoxin for transplantation tolerance induction.